Omics databases on kidney disease: Where they can be found and how to benefit from them

Clinical Kidney Journal

Volumn 9, Issue 3, 2016, Pages 343-352

  Papadopoulos, Theofilos ^a,b   Krochmal, Magdalena ^c,d   Cisek, Katryna ^e   Fernandes, Marco ^f   Husi, Holger ^f   Stevens, Robert ^g   Bascands, Jean Loup ^a,b   Schanstra, Joost P ^a,b   Klein, Julie ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

^c Academy of Athens Biomedical Research Foundation   (Greece)

^d UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^e MOSAIQUES DIAGNOSTICS GMBH   (Germany)

^f UNIVERSITY OF GLASGOW   (United Kingdom)

^g UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Bioinformatics; Data integration; Kidney disease; Omics databases; System biology

Indexed keywords

BIOINFORMATICS; CLINICAL RESEARCH; DATA BASE; FUNCTIONAL GENOMICS; HUMAN; KIDNEY DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEOMICS; RESEARCH; REVIEW; TRANSCRIPTOMICS;

EID: 84978982715     PISSN: 20488505     EISSN: 20488513     Source Type: Journal    
DOI: 10.1093/ckj/sfv155     Document Type: Review

References (65)

1. Jiang S, Chuang PY, Liu ZH et al. The primary glomerulonephritides: a systems biology approach. Nat Rev Nephrol 2013; 9: 500-512
2. Bellazzi R. Big data and biomedical informatics: a challenging opportunity. Yearb Med Inform 2014; 9: 8-13
3. Hood L, Flores M. A personal view on systems medicine and the emergence of proactive P4 medicine: predictive, preventive, personalized and participatory. N Biotechnol 2012; 29: 613-624
4. Loupy A, Lefaucheur C, Vernerey D et al. Molecular microscope strategy to improve risk stratification in early antibody-mediated kidney allograft rejection. J Am Soc Nephrol 2014; 25: 2267-2277
5. Micheel CM, Nass SJ, Omenn GS (eds). Evolution of Translational Omics: Lessons Learned and the Path Forward. Washington, DC: National Academies Press, 2012
6. Bebek G, Koyuturk M, Price ND et al. Network biology methods integrating biological data for translational science. Brief Bioinform 2012; 13: 446-459
7. Lynn DJ, Lloyd AT, O'Farrelly C. Bioinformatics: implications for medical research and clinical practice. Clin Invest Med 2003; 26: 70-74
8. Hood L. Systems biology and p4 medicine: past, present, and future. Rambam Maimonides Med J 2013; 4: e0012
9. Vlaanderen J, Moore LE, Smith MTet al. Application of OMICS technologies in occupational and environmental health research; current status and projections. Occup Environ Med 2010; 67: 136-143
10. Hamosh A, Scott AF, Amberger JS et al. Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res 2005; 33(Database issue): D514-D517
11. Parsa A, Fuchsberger C, Kottgen A et al. Common variants in Mendelian kidney disease genes and their association with renal function. J Am Soc Nephrol 2013; 24: 2105-2117
12. Pattaro C, Kottgen A, Teumer A et al. Genome-wide association and functional follow-up reveals new loci for kidney function. PLoS Genet 2012; 8: e1002584
13. Uhlen M, Fagerberg L, Hallstrom BM et al. Proteomics. Tissuebased map of the human proteome. Science 2015; 347: 1260419
14. Cui Z, Yoshida Y, Xu B et al. Profiling and annotation of human kidney glomerulus proteome. Proteome Sci 2013; 11: 13
15. Lennon R, Byron A, Humphries JD et al. Global analysis reveals the complexity of the human glomerular extracellular matrix. J Am Soc Nephrol 2014; 25: 939-951
16. Neiman M, Hedberg JJ, Donnes PR et al. Plasma profiling reveals human fibulin-1 as candidate marker for renal impairment. J Proteome Res 2011; 10: 4925-4934
17. Hansson J, Hultenby K, Cramnert C et al. Evidence for a morphologically distinct and functionally robust cell type in the proximal tubules of human kidney. Hum Pathol 2014; 45: 382-393
18. Habuka M, Fagerberg L, Hallstrom BM et al. The kidney transcriptome and proteome defined by transcriptomics and antibody-based profiling. PLoS One 2014; 9: e116125
19. Zhang AD, Dai SX, Huang JF. Reconstruction and analysis of human kidney-specific metabolic network based on omics data. Biomed Res Int 2013; 2013: 187509
20. Kozomara A, Griffiths-Jones S. miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res 2014; 42(Database issue): D68-D73
21. Wong N, Wang X. miRDB: an online resource for microRNA target prediction and functional annotations. Nucleic Acids Res 2015; 43(Database issue): D146-D152
22. Wishart DS, Jewison T, Guo AC et al. HMDB 3. 0-The Human Metabolome Database in 2013. Nucleic Acids Res 2013; 41(Database issue): D801-D807
23. Brooksbank C, Bergman MT, Apweiler R et al. The European Bioinformatics Institute's data resources 2014. Nucleic Acids Res 2014; 42(Database issue): D18-D25
24. Yamamoto T, Langham RG, Ronco P et al. Towards standard protocols and guidelines for urine proteomics: a report on the Human Kidneyand Urine Proteome Project (HKUPP) symposium and workshop, 6 October 2007, Seoul, Korea and 1 November 2007, San Francisco, CA, USA. Proteomics 2008; 8: 2156-2159
25. Pisitkun T, Bieniek J, Tchapyjnikov D et al. High-throughput identification of IMCD proteins using LC-MS/MS. Physiol Genomics 2006; 25: 263-276
26. Simonson MS, Tiktin M, Debanne SM et al. The renal transcriptome of db/db mice identifies putative urinary biomarker proteins in patients with type 2 diabetes: a pilot study. AmJ Physiol Renal Physiol 2012; 302: F820-F829
27. Shao C, Li M, Li X et al. A tool for biomarker discovery in the urinary proteome: a manually curated human and animal urine protein biomarker database. Mol Cell Proteomics 2011; 10: M111. 010975
28. Zhao M, Li M, Li X et al. Dynamic changes of urinary proteins in a focal segmental glomerulosclerosis rat model. Proteome Sci 2014; 12: 42
29. Yuan Y, Zhang F, Wu J et al. Urinary candidate biomarker discovery in a rat unilateral ureteral obstruction model. Sci Rep 2015; 5: 9314
30. Jia L, Li X, Shao C et al. Using an isolated rat kidney model to identify kidney origin proteins in urine. PLoS One 2013; 8: e66911
31. Mischak H, Delles C, Vlahou A et al. Proteomic biomarkers in kidney disease: issues in development and implementation. Nat Rev Nephrol 2015; 11: 221-232
32. Athey BD, Cavalcoli JD, Jagadish HV et al. The NIH National Center for Integrative Biomedical Informatics (NCIBI). J Am Med Inform Assoc 2012; 19: 166-170
33. Martini S, Eichinger F, Nair V et al. Defining human diabetic nephropathy on the molecular level: integration of transcriptomic profiles with biological knowledge. Rev Endocr Metab Disord 2008; 9: 267-274
34. McKay GJ, Kavanagh DH, Crean JK et al. Bioinformatic evaluation of transcriptional regulation of WNT pathway genes with reference to diabetic nephropathy. J Diabetes Res 2016; 2016: 7684038
35. Anderberg RJ, Meek RL, Hudkins KL et al. Serum amyloid A and inflammation in diabetic kidney disease and podocytes. Lab Invest 2015; 95: 250-262
36. Chitra PS, Swathi T, Sahay R et al. Growth hormone induces transforming growth factor-beta-induced protein inpodocytes: implications for podocyte depletion and proteinuria. J Cell Biochem 2015; 116: 1947-1956
37. Wanic K, Krolewski B, Ju Wet al. Transcriptome analysis of proximal tubular cells (HK-2) exposed to urines of type 1 diabetes patients at risk of early progressive renal function decline. PLoS One 2013; 8: e57751
38. O'Donovan HC, Hickey F, Brazil DP et al. Connective tissue growth factor antagonizes transforming growth factorbeta1/Smad signalling in renal mesangial cells. Biochem J 2012; 441: 499-510
39. Brennan EP, Morine MJ, Walsh DW et al. Next-generation sequencing identifies TGF-beta1-associated gene expression profiles in renal epithelial cells reiterated in human diabetic nephropathy. Biochim Biophys Acta 2012; 1822: 589-599
40. Brosius FC III, Alpers CE. Newtargets for treatment of diabetic nephropathy: what we have learned from animal models. Curr Opin Nephrol Hypertens 2013; 22: 17-25
41. Zhang Q, Yang B, Chen X et al. Renal Gene Expression Database (RGED): a relational database of gene expression profiles in kidney disease. Database (Oxford) 2014; 2014: bau092
42. Klein J, Jupp S, Moulos P et al. The KUPKB: a novelWeb application to access multiomics data on kidney disease. FASEB J 2012; 26: 2145-2153
43. Moulos P, Klein J, Jupp S et al. The KUPNetViz: a biological network viewer for multiple-omics datasets in kidney diseases. BMC Bioinformatics 2013; 14: 235
44. Sanchez-Nino MD, Fernandez-Fernandez B, Perez-Gomez MV et al. Albumin-induced apoptosis of tubular cells is modulated by BASP1. Cell Death Dis 2015; 6: e1644
45. Fernandes M, Husi H. FP222 The Chronic Kidney Disease Database (CKDdb). Nephrol Dial Transplant 2015; 30(Suppl 3): iii141
46. Husi H, Van Agtmael T, Mullen W et al. Proteome-based systems biology analysis of the diabetic mouse aorta reveals major changes in fatty acid biosynthesis as potential hallmark in diabetes mellitus-associated vascular disease. Circ Cardiovasc Genet 2014; 7: 161-170
47. Hu ZZ, Huang H, Wu CH et al. Omics-based molecular target and biomarker identification. Methods Mol Biol 2011; 719: 547-571
48. Cisek K, Krochmal M, Klein J et al. The application of multiomics and systems biology to identify therapeutic targets in chronic kidney disease. Nephrol Dial Transplant 2015; doi: 10. 1093/ndt/gfv364
49. Meng C, Kuster B, Culhane AC et al. A multivariate approach to the integration of multi-omics datasets. BMC Bioinformatics 2014; 15: 162
50. Zou D, Ma L, Yu J et al. Biological databases for human research. Genomics Proteomics Bioinformatics 2015; 13: 55-63
51. Ayers D, Day PJ. Systems medicine: the application of systems biology approaches for modern medical research and drug development. Mol Biol Int 2015; 2015: 8
52. Vanhille P. The diabetic patient with renal insufficiency. Diabetes Metab 2000; 26(Suppl 4): 67-72
53. Kamal L, Salvatore S, Hartono C et al. Concomitance of IgA nephropathy and diabetic nephropathy in a kidney allograft: case report and review of the literature. Transplant Proc 2014; 46: 2396-2399
54. Moon PG, Lee JE, You S et al. Proteomic analysis of urinary exosomes from patients of early IgA nephropathy and thin basement membrane nephropathy. Proteomics 2011; 11: 2459-2475
55. Millioni R, Iori E, Puricelli L et al. Abnormal cytoskeletal protein expression in cultured skin fibroblasts from type 1 diabetes mellitus patients with nephropathy: a proteomic approach. Proteomics Clin Appl 2008; 2: 492-503
56. Rodriguez-Fraticelli AE, Bagwell J, Bosch-ForteaMet al. Developmental regulation of apical endocytosis controls epithelial patterning in vertebrate tubular organs. Nat Cell Biol 2015; 17: 241-250
57. Liu XD, Zhang LY, Zhu TC et al. Overexpression of miR-34c inhibits high glucose-induced apoptosis in podocytes by targeting Notch signaling pathways. Int J Clin Exp Pathol 2015; 8: 4525-4534
58. Huang L, Haylor JL, Fisher M et al. Do changes in transglutaminase activity alter latent transforming growth factor beta activation in experimental diabetic nephropathy? Nephrol Dial Transplant 2010; 25: 3897-3910
59. Berthelot L, Papista C, Maciel TTet al. Transglutaminase is essential for IgA nephropathy development acting through IgA receptors. J Exp Med 2012; 209: 793-806
60. Wei Q, Dong Z. HDAC4 blocks autophagy to trigger podocyte injury: non-epigenetic action in diabetic nephropathy. Kidney Int 2014; 86: 666-668
61. Cox SN, Sallustio F, Serino G et al. Activated innate immunity and the involvement of CX3CR1-fractalkine in promoting hematuria in patients with IgA nephropathy. Kidney Int 2012; 82: 548-560
62. Liu G, Sun Y, Li Z et al. Apoptosis induced by endoplasmic reticulum stress involved in diabetic kidney disease. Biochem Biophys Res Commun 2008; 370: 651-656
63. Sanchez-Nino MD, Benito-Martin A, Ortiz A. New paradigms in cell death in human diabetic nephropathy. Kidney Int 2010; 78: 737-744
64. Grove KJ, Voziyan PA, Spraggins JM et al. Diabetic nephropathy induces alterations in the glomerular and tubule lipid profiles. J Lipid Res 2014; 55: 1375-1385
65. Vukovic I, Bozic J, Markotic A et al. The missing link-likely pathogenetic role of GM3 and other gangliosides in the development of diabetic nephropathy. Kidney Blood Press Res 2015; 40: 306-314